Connectiverx announces exclusive partnership with veradigm to deliver high-impact point-of-care communications

Whippany, n.j.--(business wire)--connectiverx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, announced today that it has entered into a long-term strategic partnership with veradigm, an allscripts (nasdaq: mdrx) business unit, to deliver a broad portfolio of point of care prescription-related messages to patients. the three-year agreement takes effect march 1, 2021. based on this partnership and the establishment of a new pr
MDRX Ratings Summary
MDRX Quant Ranking